Kalvista Pharmaceuticals Inc (KALV) PT Raised to $61 at Jefferies

February 9, 2021 3:39 PM EST
Get Alerts KALV Hot Sheet
Price: $24.45 -2.98%

Rating Summary:
    8 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 13 | New: 41
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Jefferies analyst Maury Raycroft raised the price target on Kalvista Pharmaceuticals Inc (NASDAQ: KALV) to $61.00 (from $34.00) while maintaining a Buy rating.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change

Related Entities

Jefferies & Co